Table 2 Displays targets that significantly discriminated benign follicular adenoma (FA) from follicular variant of papillary thyroid carcinoma (FVPTC) (a) and follicular adenoma from follicular thyroid carcinoma (FTC) (b). (c) Demonstrates targets that significantly distinguished follicular adenoma from the papillary thyroid carcinoma (PTC) group (classic and follicular variants), while (d) displays the assay that showed a significant difference between papillary thyroid carcinoma and follicular thyroid carcinoma
Target | Two-tailed P-value |
---|---|
(a) P-values for FA vs FVPTC | |
MT1X | 0.0015 |
CSNKIG2 | 0.0124 |
RAB23 | <0.0001 |
HLA-DMA | 0.0390 |
HLA-DQB1 | 0.0390 |
(b) P-values for FA vs FTC | |
MT1X | 0.05 |
MT1K | 0.0446 |
RAB23 | 0.0149 |
(c) P-values for FA vs PTC | |
CSNK1G2 | 0.0010 |
HLA-DQB1 | 0.0086 |
MT1X | <0.0001 |
RAB23 | <0.0001 |
(d) P-value for FTC vs PTC | |
KRAS2 | 0.0382 |